164 related articles for article (PubMed ID: 8622921)
21. Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.
Leonidas DD; Chavali GB; Jardine AM; Li S; Shapiro R; Acharya KR
Protein Sci; 2001 Aug; 10(8):1669-76. PubMed ID: 11468363
[TBL] [Abstract][Full Text] [Related]
22. Dual site model for the organogenic activity of angiogenin.
Hallahan TW; Shapiro R; Vallee BL
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2222-6. PubMed ID: 2006161
[TBL] [Abstract][Full Text] [Related]
23. A phosphate-binding subsite in bovine pancreatic ribonuclease A can be converted into a very efficient catalytic site.
Moussaoui M; Cuchillo CM; Nogués MV
Protein Sci; 2007 Jan; 16(1):99-109. PubMed ID: 17192592
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mouse angiogenin-related protein: implications for functional studies on angiogenin.
Nobile V; Vallee BL; Shapiro R
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4331-5. PubMed ID: 8633065
[TBL] [Abstract][Full Text] [Related]
25. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
Papageorgiou AC; Shapiro R; Acharya KR
EMBO J; 1997 Sep; 16(17):5162-77. PubMed ID: 9311977
[TBL] [Abstract][Full Text] [Related]
26. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
Jenkins JL; Shapiro R
Biochemistry; 2003 Jun; 42(22):6674-87. PubMed ID: 12779322
[TBL] [Abstract][Full Text] [Related]
27. Replacing a surface loop endows ribonuclease A with angiogenic activity.
Raines RT; Toscano MP; Nierengarten DM; Ha JH; Auerbach R
J Biol Chem; 1995 Jul; 270(29):17180-4. PubMed ID: 7615514
[TBL] [Abstract][Full Text] [Related]
28. Cleavage of 3',5'-pyrophosphate-linked dinucleotides by ribonuclease A and angiogenin.
Jardine AM; Leonidas DD; Jenkins JL; Park C; Raines RT; Acharya KR; Shapiro R
Biochemistry; 2001 Aug; 40(34):10262-72. PubMed ID: 11513604
[TBL] [Abstract][Full Text] [Related]
29. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
Leonidas DD; Shapiro R; Allen SC; Subbarao GV; Veluraja K; Acharya KR
J Mol Biol; 1999 Jan; 285(3):1209-33. PubMed ID: 9918722
[TBL] [Abstract][Full Text] [Related]
30. Catalytic role for arginine 188 in the C-C hydrolase catalytic mechanism for Escherichia coli MhpC and Burkholderia xenovorans LB400 BphD.
Li C; Li JJ; Montgomery MG; Wood SP; Bugg TD
Biochemistry; 2006 Oct; 45(41):12470-9. PubMed ID: 17029402
[TBL] [Abstract][Full Text] [Related]
31. Valine 108, a chain-folding initiation site-belonging residue, crucial for the ribonuclease A stability.
Coll MG; Protasevich II; Torrent J; Ribó M; Lobachov VM; Makarov AA; Vilanova M
Biochem Biophys Res Commun; 1999 Nov; 265(2):356-60. PubMed ID: 10558871
[TBL] [Abstract][Full Text] [Related]
32. Organogenesis and angiogenin.
Vallee BL; Riordan JF
Cell Mol Life Sci; 1997 Oct; 53(10):803-15. PubMed ID: 9413551
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional solution structure of human angiogenin determined by 1H,15N-NMR spectroscopy--characterization of histidine protonation states and pKa values.
Lequin O; Thüring H; Robin M; Lallemand JY
Eur J Biochem; 1997 Dec; 250(3):712-26. PubMed ID: 9461294
[TBL] [Abstract][Full Text] [Related]
34. The homologous angiogenin and ribonuclease N-terminal fragments fold into very similar helices when isolated.
Blanco FJ; Jiménez A; Rico M; Santoro J; Herranz J; Nieto JL
Biochem Biophys Res Commun; 1992 Feb; 182(3):1491-8. PubMed ID: 1540192
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease.
Acharya KR; Shapiro R; Allen SC; Riordan JF; Vallee BL
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2915-9. PubMed ID: 8159679
[TBL] [Abstract][Full Text] [Related]
36. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
37. Network of long-range concerted chemical shift displacements upon ligand binding to human angiogenin.
Gagné D; Narayanan C; Doucet N
Protein Sci; 2015 Apr; 24(4):525-33. PubMed ID: 25450558
[TBL] [Abstract][Full Text] [Related]
38. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
Chen CZ; Shapiro R
Biochemistry; 1999 Jul; 38(29):9273-85. PubMed ID: 10413501
[TBL] [Abstract][Full Text] [Related]
39. The ribonucleolytic activity of angiogenin.
Leland PA; Staniszewski KE; Park C; Kelemen BR; Raines RT
Biochemistry; 2002 Jan; 41(4):1343-50. PubMed ID: 11802736
[TBL] [Abstract][Full Text] [Related]
40. Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange.
Harper JW; Auld DS; Riordan JF; Vallee BL
Biochemistry; 1988 Jan; 27(1):219-26. PubMed ID: 3349027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
